Female Pattern Hair Loss Treatment in Korea: Minoxidil, PRP, Exosomes, and Beyond

Female pattern hair loss (androgenetic alopecia in women) affects a substantial percentage of women — particularly through perimenopause and postmenopause, but also in younger women with hormonal contributors. The presentation differs from male pattern: diffuse thinning across the crown rather than receding hairline, often more emotionally distressing because patterns aren\'t culturally normalized for women. Korean dermatology has developed a refined toolkit; this guide walks through it.

What female pattern hair loss looks like

• Christmas-tree pattern — widening of the central part with increasing width toward the front.
• Diffuse thinning — across the crown rather than focal balding.
• Frontal hairline preservation — typically intact, distinguishing from male pattern.
• Bitemporal recession — possible in advanced cases.
• Reduced hair density with increased visible scalp.

Causes

• Genetic predisposition — primary factor.
• Androgen sensitivity — even in women with normal androgen levels, follicles can be sensitive.
• Hormonal changes — perimenopause, postmenopause, post-pregnancy, polycystic ovary syndrome.
• Iron deficiency, thyroid disease, vitamin D deficiency — modifiable contributors.
• Stress, illness — can trigger telogen effluvium that exacerbates pattern hair loss.
• Medication-induced — certain drugs accelerate hair loss.

Pre-treatment evaluation

A thorough Korean dermatology consultation typically includes:

• Medical history including hormonal status, medications, supplements.
• Scalp examination with dermoscopy.
• Pull test for active shedding.
• Blood work — iron, ferritin, thyroid panel, vitamin D, hormonal panel as indicated.
• Trichoscopy for hair shaft and follicle assessment.
• Sometimes scalp biopsy for unclear or treatment-resistant cases.

The treatment hierarchy

1. Topical minoxidil

• FDA-approved for female pattern hair loss; first-line treatment.
• 2% or 5% solutions; 5% foam often better tolerated.
• Applied to scalp twice daily.
• Visible response in 4–6 months.
• Continued use indefinitely; discontinuation reverses benefit over months.
• Side effects: scalp irritation, unwanted facial hair if migrates from scalp.

2. Oral minoxidil (low-dose)

• Increasingly used in Korean dermatology — 0.25–2.5 mg daily.
• Better adherence than topical for many patients.
• Comparable efficacy at appropriate doses.
• Side effects: facial hair, mild fluid retention, occasionally dizziness.
• Off-label but well-supported by emerging evidence.

3. Antiandrogens

• Spironolactone — most common antiandrogen for women; 50–200 mg daily.
• Cyproterone acetate — used in some Korean protocols (note: regulatory status varies internationally).
• Finasteride and dutasteride — approved in Korea for women in select situations (typically post-menopausal); off-label use otherwise. Contraindicated in patients who may become pregnant.
• Hormonal evaluation before starting; monitor periodically.

4. PRP (platelet-rich plasma) scalp injection

• Adjunct rather than primary treatment.
• 4 monthly sessions, then maintenance every 3–6 months.
• Combination with topical minoxidil produces better outcomes than either alone.
• Cost-effective at Korean clinics.

5. Exosome and growth-factor scalp treatments

• Korean clinics actively use exosome-derived scalp boosters and growth-factor preparations.
• Note: per the 2025 MFDS rule, "exosome" advertising in cosmetic context is restricted; clinical use of regulated preparations continues.
• Evidence is emerging; results variable.
• Used as adjunct to medical management.

6. Low-level laser therapy (LLLT)

• In-clinic devices and home-use caps using red-light wavelengths.
• Modest evidence as adjunct.
• Particularly ranked highly in meta-analysis for female pattern.
• Painless, no recovery.

7. Hair transplantation

• FUE or DHI techniques.
• Special considerations for women — typically less recession to address; more diffuse density issues.
• Donor area must be stable.
• Often used for hairline refinement or specific area density.
• Less common in active diffuse pattern hair loss; medical management first.

The Korean combination protocol

A typical 2026 Korean approach:

1. Modifiable factor correction — iron, thyroid, vitamin D addressed first.
2. Topical or oral minoxidil as foundational treatment.
3. Antiandrogen if hormonal contribution is suspected (after evaluation).
4. PRP scalp series — 4 sessions, monthly.
5. Exosome or growth-factor scalp boosters — quarterly maintenance.
6. LLLT as ongoing adjunct.
7. Hair transplant consideration for select cases after stabilization.

Realistic outcomes

• Stabilization of loss — most patients on consistent therapy.
• Modest regrowth — typical with combination protocols.
• Visible density improvement in 6–12 months when adherent.
• Continued treatment indefinitely for sustained benefit.
• Reversal upon discontinuation — gradual loss of benefit if treatment stops.

Considerations for international patients

• Female pattern hair loss is a long-term medical condition, not a single procedure.
• Korean care is most valuable for initial workup, treatment design, and PRP/exosome scalp protocol initiation.
• Continuity of medical management is best at home country.
• Quarterly Korea visits for scalp protocol may be feasible for patients with regular travel.
• Document all medications and protocols for home-country physician continuity.

What to ask in your consultation

1. What is the cause of my hair loss — pattern, telogen effluvium, other?
2. What underlying contributors should be evaluated (iron, thyroid, hormonal)?
3. What medical treatment is appropriate for me?
4. What scalp procedures (PRP, exosome) make sense as adjuncts?
5. How will treatment be managed long-term?
6. When would hair transplantation be considered?

Pricing in Gangnam (2026, USD)

• Initial dermatology consultation with workup: $150–$350.
• Topical minoxidil monthly: $30–$80.
• Oral minoxidil monthly (compounded): $30–$80.
• Spironolactone monthly: $20–$50.
• Scalp PRP per session: $200–$500.
• Exosome / growth factor scalp boosters per session: $300–$700.
• LLLT cap (home device): $300–$1,200 one-time purchase.
• FUE hair transplant for women (1,500–2,500 grafts): $4,000–$8,500.

Red flags

• "Miracle" hair regrowth promises.
• Single-session "cures" without ongoing protocol.
• Hair transplantation recommended without medical management first.
• Vague "stem cell hair therapy" without specified products or protocols.
• Lack of pre-treatment evaluation for underlying contributors.

The honest framing

Female pattern hair loss is a treatable but chronic condition. Korean dermatology offers the full range of evidence-based options — medical management, adjunct procedures, transplantation when appropriate. Patients who commit to consistent treatment over months to years achieve stabilization and modest regrowth; patients seeking quick fixes are reliably disappointed. Set the expectations correctly, work with both Korean and home-country care, and the result is meaningful preservation of hair density.